Document:

Exhibit 10.5 

 

FORM OF LOCK-UP AGREEMENT

 

______, 2022

 

LanzaTech NZ, Inc.

AMCI Acquisition Corp. II

Re: Lock-up Agreement

 

Ladies and Gentlemen:

 

This letter (this “Letter”)
is being delivered to LanzaTech NZ, Inc., a Delaware corporation (“LanzaTech”), and LanzaTech Global, Inc.
(formerly known as AMCI Acquisition Corp. II), a Delaware corporation (the “Company”), in accordance with the
Agreement and Plan of Merger, dated as of March 8, 2022 (as it may be amended or supplemented from time to time, the “Merger
Agreement”), entered into by and among the Company, AMCI Merger Sub, Inc., a Delaware corporation, and LanzaTech. Capitalized
terms used but not otherwise defined in this Letter shall have the meanings ascribed thereto in the Merger Agreement.

 

In order to induce the Company
and LanzaTech to proceed with the transactions contemplated in the Merger Agreement and for good and valuable consideration, the receipt
and sufficiency of which are hereby acknowledged, the undersigned hereby agrees with LanzaTech and the Company as follows:

 

		1.	Definitions.

 

The
following terms shall, for all purposes of this Letter, have the respective meanings set forth below:

 

“Affiliate”
means, with respect to any specified person, any other person or entity that, directly or indirectly, is controlled by such specified
person, whether through one or more intermediaries or otherwise. The term “control” (including the term “controlled
by”) means the possession, directly or indirectly, of the power to direct or cause the direction of the management and policies
of a person or entity, whether through the ownership of voting securities, by contract or otherwise.

 

“Commission”
shall mean the Securities and Exchange Commission.

 

“Common Stock”
shall mean common stock of the Company, par value $0.0001 per share.

 

“Exchange Act”
shall mean the Securities Exchange Act of 1934, as amended from time to time.

 

“Lock-up Period”
shall mean the period beginning on the date of the Closing and ending on: (a) if the undersigned is a director or officer of LanzaTech
on the date hereof, then, with respect to the undersigned and his or her Permitted Transferees, the earlier of (i) the date that
is 12 months from the date of the Closing, (ii) such time when the closing price of the Common Stock shall have equaled or exceeded
$12.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days
within any 30-trading day period commencing at least 150 days after the date of the Closing, and (iii) the date on which the Company
completes a liquidation, merger, capital stock exchange, reorganization or other similar transaction after the date of the Closing that
results in all of the Company’s stockholders having the right to exchange their shares of Common Stock for cash, securities or other
property, and (b) if the undersigned is an employee (but not a director or officer) of LanzaTech or a subsidiary of LanzaTech on
the date hereof (an “Employee”), then, with respect to the undersigned and his or her Permitted Transferees,
the date that is six months from the date of the Closing.

 

     

     

    

 

“Permitted Transfer”
shall mean a Transfer of shares of Common Stock or Related Securities (a) to any Affiliate of the undersigned, (b) by gift to
a member of the immediate family of the undersigned (for purposes of this Letter, “immediate family” shall mean any of the
following: such person’s spouse, the siblings of such person, the siblings of such person’s spouse, and the direct descendants
and ascendants (including adopted and step children and parents) of such person and of such person’s spouse and of such person’s
siblings) or to a trust, the beneficiary of which is the undersigned or a member of the immediate family of the undersigned, or to a charitable
organization, (c) by virtue of laws of descent and distribution upon death of the undersigned, (d) pursuant to a qualified domestic
relations order, or (e) in connection with the Company’s liquidation, merger, capital stock exchange, reorganization, tender
offer, exchange offer or other similar transaction after the date hereof which results in all of the Company’s stockholders having
the right to exchange their shares of Common Stock for cash, securities or other property; provided, however, that in the
case of clauses (a) through (e), the applicable transferee(s) must enter into a written agreement with the Company
agreeing to be bound by the transfer restrictions herein and the other restrictions contained in this Letter.

 

“Permitted Transferee”
shall mean the applicable transferee of any shares of Common Stock or Related Securities pursuant to a Permitted Transfer.

 

“Related Securities”
shall mean any options or warrants or other rights to acquire shares of Common Stock or any securities exchangeable or exercisable for
or convertible into shares of Common Stock, or to acquire other securities or rights ultimately exchangeable or exercisable for or convertible
into shares of Common Stock.

 

“Transfer”
shall mean the (a) sale or assignment of, offer to sell, contract or agreement to sell, hypothecate, pledge, grant of any option
to purchase or otherwise dispose of or agreement to dispose of, directly or indirectly, or establishment or increase of a put equivalent
position or liquidation with respect to or decrease of a call equivalent position within the meaning of Section 16 of the Exchange
Act, and the rules and regulations of the Commission promulgated thereunder with respect to, any security, (b) entry into any
swap or other arrangement that transfers to another, in whole or in part, any of the economic consequences of ownership of any security,
whether any such transaction is to be settled by delivery of such securities, in cash or otherwise, or (c) public announcement of
any intention to effect any transaction specified in clause (a) or (b).

 

    	 	2	 

     

    

 

		2.	Lock-up.

 

		a.	The undersigned, on behalf of himself or herself and any of his or her Affiliates, agrees not to Transfer,
in whole or in part, his or her shares of Common Stock or Related Securities, whether (i) held by the undersigned or an Affiliate
of the undersigned immediately following the Closing or issuable to the undersigned or an Affiliate of the undersigned pursuant to the
Merger Agreement and (ii) any such transaction is to be settled by delivery of shares of Common Stock or Related Securities or other
securities, in cash or otherwise, during the Lock-up Period applicable to the undersigned. Notwithstanding the foregoing, during the applicable
Lock-up Period: (A) the undersigned may Transfer his or her shares of Common Stock or Related Securities to any Permitted Transferee
of the undersigned; provided that such Permitted Transferee shall enter into a written agreement, in substantially the form of
this Letter (it being understood that any references to “immediate family” in the agreement executed by such transferee shall
expressly refer only to the immediate family of the undersigned and not to the immediate family of the transferee), agreeing to be bound
by these Transfer restrictions; (B) subject to applicable securities laws, the undersigned may Transfer shares of Common Stock or
Related Securities for up to such number of shares of Common Stock or Related Securities to the Company for the purpose of satisfying
any withholding taxes (including estimated taxes) due upon the exercise of any stock options or the vesting of any restricted shares,
restricted stock units or similar equity awards granted by the Company to the undersigned; (C) subject to applicable securities laws
and the terms of any applicable equity incentive plan or award agreement, as amended from time to time, the undersigned may Transfer shares
of Common Stock or Related Securities to the Company for the purpose of effecting a “net settlement” or “net exercise”
whereby the undersigned would Transfer shares of Common Stock or Related Securities to the Company to cover the total cost of exercise
arising in connection with the exercise of any stock options or similar equity awards granted by the Company to the undersigned; and (D) if
the undersigned is an Employee, the undersigned may Transfer shares of Common Stock or Related Securities in a number equal to 10% of
the sum of (x) the shares of Common Stock or Related Securities held by the undersigned or which the undersigned has the right to
receive pursuant to the Merger Agreement, in each case immediately following the Closing plus (y) any shares of Common Stock
underlying any stock options, restricted shares, restricted stock units or similar equity awards granted by the Company to the undersigned
and outstanding as of the date hereof.

 

		b.	If any Transfer prohibited by this Letter is made or attempted contrary to the provisions of this Letter,
such purported Transfer shall be null and void ab initio, and the Company shall refuse to recognize any such purported transferee
of the shares of Common Stock or Related Securities as one of its equity holders for any purpose. In order to enforce this, the Company
may impose stop-transfer instructions with respect to the shares of Common Stock or Related Securities of the undersigned (and his or
her permitted assigns, including Permitted Transferees) until the end of the applicable Lock-up Period.

 

		c.	For the avoidance of doubt, the undersigned shall retain all of his or her rights as a stockholder of
the Company with respect to the shares of Common Stock during the Lock-up Period applicable to the undersigned, including the right to
vote any shares of Common Stock that are entitled to vote.

 

    	 	3	 

     

    

 

		3.	Miscellaneous.

 

		a.	The undersigned hereby represents and warrants that the undersigned has full power and authority to execute
and deliver this Letter and that this Letter constitutes the legal, valid and binding obligation of the undersigned, enforceable in accordance
with its terms. Upon request, the undersigned will execute any additional documents necessary in connection with enforcement hereof. The
undersigned may not assign this Letter or any of his or her rights, interests or obligations hereunder without the prior written consent
of the Company. Any purported assignment in violation of this paragraph shall be void and ineffectual and shall not operate to transfer
or assign any interest or title to the purported assignee. Any obligations of the undersigned shall be binding upon the successors and
permitted assigns of the undersigned from and after the date hereof.

 

		b.	This Letter shall automatically terminate upon the earlier to occur of (i) the expiration of the applicable
Lock-Up Period, (ii) the termination of the Merger Agreement and (iii) if the undersigned is an Employee, the termination
of the employment relationship of the undersigned with LanzaTech or a subsidiary of LanzaTech.

 

		c.	This Letter may not be changed, amended, modified or waived (other than to correct a typographical error)
as to any particular provision, except by a written instrument executed by the undersigned and the Company.

 

		d.	This Letter shall be governed by, and construed in accordance with, the laws of the State of New York.

 

[Signature Page Follows]

 

    	 	4	 

     

    

 

		Very truly yours,
	 	 
	 	 
	 	Name:	[  ]
	 	Title:	[  ]

 

[Signature Page to Lock-up
Agreement]EX-4.10

  Exhibit 4.10

   

  DESCRIPTION OF CAPITAL STOCK

   

  The following is a summary of information concerning capital stock of Corbus Pharmaceuticals Holdings, Inc. (“us,” “our,” “we” or the “Company”) and certain provisions of our amended and restated certificate of incorporation and amended and restated bylaws currently in effect. This summary does not purport to be complete and is qualified in its entirety by the provisions of our amended and restated certificate of incorporation, as amended (the “Certificate of Incorporation”), and amended and restated bylaws (the “Bylaws”), each previously filed with the Securities and Exchange Commission (“SEC”) and incorporated by reference as an exhibit to the Annual Report on Form 10-K, as well as to the applicable provisions of the Delaware General Corporation Law (the “DGCL”). We encourage you to read our Certificate of Incorporation, Bylaws and the applicable portions of the DGCL carefully.

   

  General

   

  Our authorized capital stock consists of:

   

  			
	 
	●
	300,000,000 shares of common stock, par value $0.0001 per share; and 

	 
	 
	 

	 
	●
	10,000,000 shares of preferred stock, par value $0.0001 per share, of which, as of the date of this prospectus, none of which shares have been designated.

   

  As of December 31, 2021, 125,230,881 shares of common stock were issued and outstanding and no shares of preferred stock were issued and outstanding.

   

  Common Stock.

   

  Voting. The holders of our common stock are entitled to one vote for each share held of record on all matters on which the holders are entitled to vote (or consent pursuant to written consent). Directors are elected by a plurality of the votes present in person or represented by proxy and entitled to vote.

   

  Dividends. The holders of our common stock are entitled to receive, ratably, dividends only if, when and as declared by our board of directors out of funds legally available therefor and after provision is made for each class of capital stock having preference over the common stock.

   

  Liquidation Rights. In the event of our liquidation, dissolution or winding-up, the holders of common stock are entitled to share, ratably, in all assets remaining available for distribution after payment of all liabilities and after provision is made for each class of capital stock having preference over the common stock.

   

  Conversion Right. The holders of our common stock have no conversion rights.

   

  Preemptive and Similar Rights. The holders of our common stock have no preemptive or similar rights.

   

  Redemption/Put Rights. There are no redemption or sinking fund provisions applicable to the common stock. All of the outstanding shares of our common stock are fully-paid and nonassessable. 

   

  Anti-takeover Effects of Delaware Law and our Certificate of Incorporation and Bylaws 

   

  Our Certificate of Incorporation and Bylaws contain provisions that could have the effect of discouraging potential acquisition proposals or tender offers or delaying or preventing a change of control. They are also designed, in part, to encourage persons seeking to acquire control of us to negotiate first with our board of directors. These provisions are as follows:

   

  

  			
	 
	●
	they provide that special meetings of stockholders may be called only by the board of directors acting pursuant to a resolution approved by the affirmative vote of a majority of the board of directors; 

	 
	●
	they specifically deny the ability of stockholders to take action by written consent of the stockholders in lieu of a meeting;

	 
	●
	they do not include a provision for cumulative voting in the election of directors. Under cumulative voting, a minority stockholder holding a sufficient number of shares may be able to ensure the election of one or more directors. The absence of cumulative voting may have the effect of limiting the ability of minority stockholders to effect changes to the our board of directors; and

	 
	●
	they allow us to issue, without stockholder approval, up to 10,000,000 shares of preferred stock, with such designations, rights, and preferences as may be determined from time to time by our board of directors that could adversely affect the rights and powers of the holders of the common stock, including dividend, liquidation, conversion, voting, or other rights that could adversely affect the voting power or other rights of the holders of our common stock. The issuance of preferred stock could have the effect of restricting dividends on our common stock, diluting the voting power of our common stock, impairing the liquidation rights of our common stock, or delaying or preventing a change in control of our company, all without further action by our stockholders.

   

  We are subject to the provisions of Section 203 of the DGCL. In general, Section 203 prohibits a publicly held Delaware corporation from engaging in a “business combination” with an “interested stockholder” for a period of three years after the date of the transaction in which the person became an interested stockholder, unless the business combination is approved in the following prescribed manner:

   

  			
	 
	●
	prior to the time of the transaction, the board of directors of the corporation approved either the business combination or the transaction which resulted in the stockholder becoming an interested stockholder;

	 
	●
	upon completion of the transaction that resulted in the stockholder becoming an interested stockholder, the stockholder owned at least 85% of the voting stock of the corporation outstanding at the time the transaction commenced, excluding for purposes of determining the number of shares outstanding (1) shares owned by persons who are directors and also officers and (2) shares owned by employee stock plans in which employee participants do not have the right to determine confidentially whether shares held subject to the plan will be tendered in a tender or exchange offer; and

	 
	●
	on or subsequent to the time of the transaction, the business combination is approved by the board and authorized at an annual or special meeting of stockholders, and not by written consent, by the affirmative vote of at least 66 2/3% of the outstanding voting stock which is not owned by the interested stockholder.

   

  Generally, for purposes of Section 203, a “business combination” includes a merger, asset or stock sale, or other transaction resulting in a financial benefit to the interested stockholder. An “interested stockholder” is a person who, together with affiliates and associates, owns or, within three years prior to the determination of interested stockholder status, owned 15% or more of a corporation’s outstanding voting securities.

   

  Listing

   

  Our common stock is listed on The Nasdaq Global Market under the symbol “CRBP.”

   

  Transfer Agent and Registrar

   

  The transfer agent and registrar for our common stock is Continental Stock Transfer & Trust Company, LLC.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00341-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00341-of-00352.parquet"}]]